1. BRCA1/2 mutations and risk‐reducing bilateral salpingo‐oophorectomy among Latinas: The UPTAKE study. Issue 2 (3rd October 2020) Authors: Lynce, Filipa; Schlam, Ilana; Geng, Xue; Peshkin, Beth N.; Friedman, Sue; Dutil, Julie; Nahleh, Zeina; Campos, Claudia; Ricker, Charité; Rodriguez, Patricia; Denduluri, Neelima; Ahn, Jaeil; Isaacs, Claudine; Graves, Kristi D. Journal: Journal of genetic counseling Issue: Volume 30:Issue 2(2021) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CTIM-02. TIP: PHASE I/II STUDY OF STEREOTACTIC RADIOSURGERY WITH CONCURRENT OLAPARIB FOLLOWED BY ADJUVANT DURVALUMAB AND PHYSICIAN'S CHOICE SYSTEMIC THERAPY IN SUBJECTS WITH BREAST CANCER BRAIN METASTASES. (14th November 2022) Authors: Shen, Colette; Abdou, Yara; Tan, Xianming; Gupta, Gaorav; Lynce, Filipa; Stringer-Reasor, Erica; Anders, Carey Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. D84. Pre-operative Lymphedema Risk Factors in Patients with Inflammatory Breast Cancer: Optimizing Patient Selection for LYMPHA. (26th April 2023) Authors: Hyland, Colby J.; Copeland-Halperin, Libby R.; Xiang, David; Gadiraju, Goutam; Bellon, Jennifer R.; Lynce, Filipa; Dey, Tanujit; Ryan, Sean J.; Nakhlis, Faina; Broyles, Justin M. Journal: Plastic and reconstructive surgery Issue: Volume 11(2023)Supplement S4 Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer. (July 2022) Authors: Pernas, Sonia; Guerriero, Jennifer L.; Naumenko, Sergey; Goel, Shom; Regan, Meredith M.; Hu, Jiani; Harrison, Beth T.; Lynce, Filipa; Lin, Nancy U.; Partridge, Ann; Morikawa, Aki; Hutchinson, John; Mittendorf, Elizabeth A.; Sokolov, Artem; Overmoyer, Beth Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer. Issue 19 (22nd June 2021) Authors: Lynce, Filipa; Blackburn, Matthew J.; Zhuo, Rebecca; Gallagher, Christopher; Hahn, Olwen M.; Abu‐Khalaf, Maysa; Mohebtash, Mahsa; Wu, Tianmin; Pohlmann, Paula R.; Dilawari, Asma; Tiwari, Shruti R.; Chitalia, Ami; Warren, Robert; Tan, Ming; Shajahan‐Haq, Ayesha N.; Isaacs, Claudine Journal: Cancer Issue: Volume 127:Issue 19(2021) Page Start: 3622 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications. (October 2022) Authors: Tarantino, Paolo; Niman, Samuel M.; Erick, Timothy K.; Priedigkeit, Nolan; Harrison, Beth T.; Giordano, Antonio; Nakhlis, Faina; Bellon, Jennifer R.; Parker, Tonia; Strauss, Sarah; Jin, Qingchun; King, Tari A.; Overmoyer, Beth A.; Curigliano, Giuseppe; Regan, Meredith M.; Tolaney, Sara M.; Lynce,... Journal: European journal of cancer Issue: Volume 174(2022) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Management of Cardiovascular Disease in Women With Breast Cancer. Issue 8 (19th February 2019) Authors: Barish, Rachel; Lynce, Filipa; Unger, Keith; Barac, Ana Journal: Circulation Issue: Volume 139:Issue 8(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pertuzumab for the Treatment of Breast Cancer. (14th September 2014) Authors: Lynce, Filipa; Swain, Sandra M. Journal: Cancer investigation Issue: Volume 32:Number 8(2014) Page Start: 430 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. SAFE‐HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2‐Positive Breast Cancer and Reduced Left Ventricular Function. (17th March 2017) Authors: Lynce, Filipa; Barac, Ana; Tan, Ming T.; Asch, Federico M.; Smith, Karen L.; Dang, Chau; Isaacs, Claudine; Swain, Sandra M. Journal: Oncologist Issue: Volume 22:Number 5(2017) Page Start: 518 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. SAFE‐HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2‐Positive Breast Cancer and Reduced Left Ventricular Function. (May 2017) Authors: Lynce, Filipa; Barac, Ana; Tan, Ming T.; Asch, Federico M.; Smith, Karen L.; Dang, Chau; Isaacs, Claudine; Swain, Sandra M. Journal: Oncologist Issue: Volume 22:Number 5(2017) Page Start: 518 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗